Quillivant XR 25 MG/5 ML susp 180ML
Ended Awarded Last action
- Contract number
- SPE2DR26F97T2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,724
Award facts
- Contract value 100% obligated
- $1,723.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,723.93 delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml). This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is scheduled for completion by January 27, 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Quillivant XR is a prescription medication used in the treatment of attention-deficit/hyperactivity disorder (ADHD). AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills orders for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains for military and veteran healthcare systems. This delivery order represents routine pharmaceutical procurement within the broader scope of the DLA's medical supply chain operations supporting the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F97T2?
SPE2DR26F97T2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F97T2 worth?
The government has obligated $1,724 on SPE2DR26F97T2.
Is contract SPE2DR26F97T2 an order under another contract?
Yes. SPE2DR26F97T2 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F97T2 competed?
The extent of competition for SPE2DR26F97T2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award